D-1293-2020 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1293-2020 was initiated by American Health Packaging on May 19, 2020 and is designated Class II. Reason for recall: Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life). The recall status is terminated (terminated Aug 3, 2022). Affected quantity: 15,755 cartons.

Recall details

Product Type
Drugs
Report Date
Jun 17, 2020
Initiation Date
May 19, 2020
Termination Date
Aug 3, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,755 cartons

Product description

Doxycycline Hyclate Tablets, USP, 100 mg, 30 Tablets per carton (3 x 10), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC Carton 62584-693-21; NDC Unit Dose 62584-693-11

Reason for recall

Failed dissolution specification - dissolution results of 59% (spec. NLT 85%) at the 24 month time point (end of shelf life).

Distribution pattern

USA Nationwide

Code information

Lots 179605, Exp 06/30/2020; 181105, Exp 08/31/2020; 183019, Exp 01/31/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1293-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1293-2020. Report a data issue: hello@regdatalab.com.